Core Viewpoint - Xilong Science has shown a significant stock price increase this year, with a notable rise in trading activity and fluctuations in net inflow and outflow of funds [1][2]. Group 1: Stock Performance - As of September 24, Xilong Science's stock price increased by 2.03%, reaching 9.56 CNY per share, with a total market capitalization of 5.595 billion CNY [1]. - The stock has risen 32.96% year-to-date, with a 11.68% increase over the last five trading days and a 7.66% increase over the last twenty days, while it has decreased by 3.43% over the last sixty days [1]. - The company has appeared on the trading leaderboard four times this year, with the most recent instance on May 23, where it recorded a net buy of -89.7156 million CNY [1]. Group 2: Financial Performance - For the first half of 2025, Xilong Science reported a revenue of 3.368 billion CNY, representing a year-on-year decrease of 14.78%, and a net profit attributable to shareholders of -75.3173 million CNY, a decline of 276.35% [2]. - The company has distributed a total of 2.17 billion CNY in dividends since its A-share listing, with 31.0165 million CNY distributed over the past three years [3]. Group 3: Business Overview - Xilong Science, established on July 19, 1994, and listed on June 2, 2011, is primarily engaged in the research, production, and sales of chemical reagents, with a revenue composition of 62.60% from specialized chemicals, 15.12% from chemical raw materials, and 9.66% from electronic chemicals [2]. - The company operates within the electronic chemical industry and is involved in various sectors, including gene sequencing, nuclear pollution prevention, photolithography, food safety, and assisted reproduction [2].
西陇科学涨2.03%,成交额2.66亿元,主力资金净流入676.52万元